Business Context and Reporting Period
Company: Definitive Healthcare Corp.
Filing Type: Form 8-K (Current Report)
Date of Report: September 2, 2026
Event: Announcement of a non-binding acquisition proposal.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity for the reporting period. The document focuses exclusively on a corporate transaction event.
Material Changes and Transaction Details
On September 2, 2026, the Company's Special Committee received a non-binding proposal from Advent International, L.P. (Advent) to acquire the Company. Key terms include:
- Proposed Buyer: Advent International, L.P., on behalf of certain managed funds.
- Target Assets: All outstanding shares of Class A Common Stock and all outstanding limited liability company interests of AIDH TopCo, LLC (Definitive OpCo Units) not already owned by Advent or founder Jason Krantz.
- Offer Price: $1.02 per share of Class A Common Stock and an equivalent amount per Definitive OpCo Unit.
- Consideration Type: All cash.
- Status: Non-binding proposal.
Guidance, Outlook, and Risks
The filing does not contain updated financial guidance, management commentary on future operations, or specific risk factors beyond the context of the proposed transaction. The proposal is currently non-binding, and no definitive agreement has been reached.
Investor Verification Checklist
- Verify the current market price of Class A Common Stock relative to the $1.02 per share offer.
- Confirm the ownership stakes of Advent International and Jason Krantz to determine the percentage of shares subject to the offer.
- Monitor for subsequent filings regarding the Special Committee's response or the negotiation of a definitive agreement.
- Review the attached press release (Exhibit 99.1) for additional context on the proposal's conditions.